- Research works
- 1 ▼ 100% vs 2013–17
- Citations
- 10 8.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 4% world 28%
Not ranked overall: Trials Italiani in Oncologia Medica is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Trials Italiani in Oncologia Medica publish most on?
By volume: Neuroendocrine Tumor Research Advances, Neuroblastoma Research and Treatments, Lung Cancer Research Studies and Breast Cancer Treatment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neuroendocrine Tumor Research Advances Epidemiology 0 works
- 2 Neuroblastoma Research and Treatments Neurology 0 works
- 3 Lung Cancer Research Studies Oncology 0 works
- 4 Breast Cancer Treatment Studies Cancer Research 0 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 6 Global Cancer Incidence and Screening Oncology 0 works
- 7 Bone health and treatments Oncology 0 works
- 8 Estrogen and related hormone effects Genetics 0 works
- 9 HER2/EGFR in Cancer Research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Trials Italiani in Oncologia Medica's research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
Other research institutions in Monza
- Azienda Ospedaliera San Gerardo
- Mylan (Italy)
- Project Automation (Italy)
- Trivella (Italy)
- Fondazione Matilde Tettamanti Menotti De Marchi
- Biblioteca Italiana per i Ciechi "Regina Margherita" - ONLUS
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.